Table 2.
Summary of the literature review results (animal models and cell lines)
Author | Year | Country | Aim | Methodology | Sample size | Subjects | Antipsychotics | Duration | Key findings |
---|---|---|---|---|---|---|---|---|---|
Shamshoum et al. [30] | 2021 | Canada | To review the peripheral mechanisms of acute olanzapine-induced related metabolic disturbances | Narrative review | Clozapine and olanzapine | Preclinical in vivo studies in this review revealed gender-specific changes in glucose metabolism in response to Aps | |||
Ren et al. [28] | 2019 | China | To investigate olanzapine-induced insulin-desensitivity in the liver | Animal study | Rats | Olanzapine | IRS/PI3K/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats | ||
Nagata et al. [41] | 2018 | Japan | To clarify the mechanism of clozapine-induced acute hyperglycemia | Animal study | Wistar rat | Clozapine | Single clozapine administration raised rat serum glucose levels | ||
Liu et al. [31] | 2017 | Australia | To evaluate the longitudinal changes in glucose-lipid homeostasis after SGA use for 9 weeks in rats | Animal study | Rat | Clozapine and olanzapine | SGA-induced glucose-lipid metabolic disturbances may occur independently of weight gain, potentially via liver SREBP/ChREBP activation | ||
Castellani et al. [43] | 2017 | Canada | To investigate glucagon’s role in mediating olanzapine-induced blood glucose increase | Animal study | WT mice, Gcgr-/- mice | Olanzapine | Central role of the liver in mediating olanzapine-induced disturbances in glucose homeostasis | ||
Mondelli et al. [29] | 2013 | UK | To find the molecular pathways of haloperidol- and olanzapine-induced metabolic abnormalities | Animal study | Sprague-Dawley rat | Olanzapine and haloperidol | Different molecular pathways mediate glucose homeostasis disturbances induced by haloperidol and olanzapine, with olanzapine directly affecting the insulin pathway | ||
Panariello et al. [33] | 2012 | Italy | To investigate the effect of clozapine on insulin action by analyzing insulin signaling in vitro and in vivo | Laboratory and animal study | PCI2, L6 cells and C57/BL/KsJ mice | Clozapine | Clozapine impairs insulin signaling and glucose uptake by affecting Akt and PKC-z | ||
Smith et al. [42] | 2009 | New Zealand | To compare the effects of clozapine and quetiapine on the development of obesity and glucose metabolism. | Animal study | Sprague-Dawley rat | Clozapine and quetiapine | Clozapine and quetiapine impair glucose tolerance in rats independently of obesity-induced insulin resistance | ||
Smith et al. [40] | 2008 | New Zealand | To investigate the impact of SGAs on glucose metabolism | Animal study | Rat | Haloperidol, quetiapine, and clozapine | SGAs induce acute disruptions in glucose metabolism through increased glucagon secretion | ||
Engl et al. [32] | 2005 | Austria | To find pathogenesis of SGA-induced disturbance of glucose homeostasis | Laboratory study | L6 skeletal muscle cell | Olanzapine | Olanzapine reduces glycogen content in L6 cells by inhibiting insulin signaling |
DM, diabetes mellitus; DKA, diabetic ketoacidosis; FGAs, first-generation antipsychotics; SGAs, second-generation antipsychotics; APs, antipsychotics; WP, wild type